341 related articles for article (PubMed ID: 16421157)
1. Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients.
Golestaneh L; Laut J; Rosenberg S; Zhang M; Mokrzycki MH
Nephrol Dial Transplant; 2006 May; 21(5):1328-33. PubMed ID: 16421157
[TBL] [Abstract][Full Text] [Related]
2. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality.
Mokrzycki MH; Zhang M; Cohen H; Golestaneh L; Laut JM; Rosenberg SO
Nephrol Dial Transplant; 2006 Apr; 21(4):1024-31. PubMed ID: 16449293
[TBL] [Abstract][Full Text] [Related]
3. Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.
Koch M; Kohnle M; Trapp R; Haastert B; Rump LC; Aker S
Nephrol Dial Transplant; 2012 Jan; 27(1):375-80. PubMed ID: 21622993
[TBL] [Abstract][Full Text] [Related]
4. UK Renal Registry 11th Annual Report (December 2008): Chapter 12 Epidemiology of Methicillin Resistant Staphylococcus aureus bacteraemia amongst patients receiving Renal Replacement Therapy in England in 2007.
Fluck R; Wilson J; Davies J; Blackburn R; O'Donoghue D; Tomson CR
Nephron Clin Pract; 2009; 111 Suppl 1():c247-56. PubMed ID: 19542700
[TBL] [Abstract][Full Text] [Related]
5. An interventional controlled trial comparing 2 management models for the treatment of tunneled cuffed catheter bacteremia: a collaborative team model versus usual physician-managed care.
Mokrzycki MH; Zhang M; Golestaneh L; Laut J; Rosenberg SO
Am J Kidney Dis; 2006 Oct; 48(4):587-95. PubMed ID: 16997055
[TBL] [Abstract][Full Text] [Related]
6. Prospective follow-up of a novel design haemodialysis catheter; lower infection rates and improved survival.
Weijmer MC; Vervloet MG; ter Wee PM
Nephrol Dial Transplant; 2008 Mar; 23(3):977-83. PubMed ID: 17984107
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
Chen SC; Lawrence RH; Byth K; Sorrell TC
Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
[TBL] [Abstract][Full Text] [Related]
8. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
9. [Tesio twin catheter system for hemodialysis tunnelized using an echo-guided technique. Retrospective analysis of 210 catheters].
Ibrik O; Samon R; Roca R; Viladoms J; Mora J
Nefrologia; 2006; 26(6):719-25. PubMed ID: 17227250
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of three strategies of managing tunnelled, cuffed haemodialysis catheters in clinically mild or asymptomatic bacteraemias.
Mokrzycki MH; Singhal A
Nephrol Dial Transplant; 2002 Dec; 17(12):2196-203. PubMed ID: 12454233
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for increased variability in dialysis delivery in haemodialysis patients.
Brimble KS; Treleaven DJ; Onge JS; Carlisle EJ
Nephrol Dial Transplant; 2003 Oct; 18(10):2112-7. PubMed ID: 13679488
[TBL] [Abstract][Full Text] [Related]
12. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
[TBL] [Abstract][Full Text] [Related]
13. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.
Labriola L; Crott R; Jadoul M
Nephrol Dial Transplant; 2008 May; 23(5):1666-72. PubMed ID: 18065789
[TBL] [Abstract][Full Text] [Related]
14. Bacteremia associated with tunneled, cuffed hemodialysis catheters.
Saad TF
Am J Kidney Dis; 1999 Dec; 34(6):1114-24. PubMed ID: 10585322
[TBL] [Abstract][Full Text] [Related]
15. Catheter-related bacteraemia in haemodialysis patients with HIV infection.
Mitchell D; Krishnasami Z; Allon M
Nephrol Dial Transplant; 2006 Nov; 21(11):3185-8. PubMed ID: 16891646
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters.
Johnson DW; MacGinley R; Kay TD; Hawley CM; Campbell SB; Isbel NM; Hollett P
Nephrol Dial Transplant; 2002 Oct; 17(10):1802-7. PubMed ID: 12270988
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.
Saxena AK; Panhotra BR; Sundaram DS; Morsy MN; Al-Ghamdi AM
Nephrology (Carlton); 2006 Aug; 11(4):299-305. PubMed ID: 16889569
[TBL] [Abstract][Full Text] [Related]
18. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use.
Weijmer MC; Vervloet MG; ter Wee PM
Nephrol Dial Transplant; 2004 Mar; 19(3):670-7. PubMed ID: 14767025
[TBL] [Abstract][Full Text] [Related]
19. Genomic species identification is important to delineate the pathological characteristics of Acinetobacter in tunnelled, cuffed haemodialysis catheter-related bacteraemia.
Chen TL; Chuang CL; Siu LK; Fung CP; Cho WL
Nephrol Dial Transplant; 2007 Mar; 22(3):936-8. PubMed ID: 17210598
[No Abstract] [Full Text] [Related]
20. Inserting tunnelled hemodialysis catheters using elective guidewire exchange from nontunnelled catheters: is there a greater risk of infection when compared with new-site replacement?
Casey J; Davies J; Balshaw-Greer A; Taylor N; Crowe AV; McClelland P
Hemodial Int; 2008 Jan; 12(1):52-4. PubMed ID: 18271841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
